Biotech Values

[DewDiligence]

I draw a distinction between placebo patients thinking they improved on some subjective measure such as pain or anxiety and a verifiable improvement in an objective clinical metric (in this case confirmed by before-and-after liver biopsies).

Over time, NASH patients do sometimes get better on their own, and hence it’s cheating for Genfit to exclude a portion of the dataset from this trial because of such outcomes in the control arm.